Stay updated on Oral PHA-022121 Dose-ranging Clinical Trial
Sign up to get notified when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.

Latest updates to the Oral PHA-022121 Dose-ranging Clinical Trial page
- Check3 days agoChange DetectedA new revision labeled v3.5.2 was added, and the previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision history shows the addition of site revision v3.5.0 and the removal of v3.4.3.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision entry v3.4.3 is added, replacing the previous v3.4.2. No substantive data or public content changes are indicated.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry (v3.4.2) was added, and older notices including a funding-status message and Revision: v3.4.1 were deleted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check75 days agoChange DetectedRevision updated to v3.4.1 (replacing v3.4.0) and a site-wide notice about government funding; these are metadata changes and do not affect the study record content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check82 days agoChange DetectedThe new version adds a glossary display option, a color-coding legend for changes (green/red highlights), and updates the revision label to v3.4.0, replacing v3.3.4.SummaryDifference0.7%

Stay in the know with updates to Oral PHA-022121 Dose-ranging Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.